Production (Stage)
Chemed Corporation
CHE
$569.57
$8.131.45%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.09% | 5.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.09% | 5.58% | |||
| Cost of Revenue | 6.07% | 2.45% | |||
| Gross Profit | -7.56% | 11.49% | |||
| SG&A Expenses | 1.28% | 2.23% | |||
| Depreciation & Amortization | 1.17% | 0.85% | |||
| Other Operating Expenses | 117.71% | -281.13% | |||
| Total Operating Expenses | 5.04% | 2.27% | |||
| Operating Income | -17.11% | 24.05% | |||
| Income Before Tax | -20.35% | 18.90% | |||
| Income Tax Expenses | -19.75% | 18.02% | |||
| Earnings from Continuing Operations | -20.55% | 19.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.55% | 19.19% | |||
| EBIT | -17.11% | 24.05% | |||
| EBITDA | -11.98% | 16.69% | |||
| EPS Basic | -19.30% | 20.57% | |||
| Normalized Basic EPS | -19.39% | 20.72% | |||
| EPS Diluted | -19.35% | 20.51% | |||
| Normalized Diluted EPS | -19.42% | 20.74% | |||
| Average Basic Shares Outstanding | -1.56% | -1.14% | |||
| Average Diluted Shares Outstanding | -1.52% | -1.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.23% | -0.16% | |||